IL1B and breast carcinoma: When conducting a systematic research review, Salignan’s team proved that increased symptoms of fatigue, especially in women in early stages of breast cancer, were caused by increased concentrations of IL-6 and TNF, and of IL-1β during chemotherapy, and of IL-6 during radiotherapy [72].